SPIOMET4HEALTH | Ongoing clinical trials on Polycystic Ovary Syndrome (PCOS)

The study, within the SPIOMET4HEALTH project, part of the Horizon programme and funded by the European Commission, will be carried out in Spain, Italy, Denmark, Turkey, Austria and Norway.

The study, within the SPIOMET4HEALTH project, part of the Horizon programme and funded by the European Commission, will be carried out in Spain, Italy, Denmark, Turkey, Austria and Norway.
February 7, 2024

An international clinical trial is underway to evaluate on a large scale the effects of the first specific treatment for Polycystic Ovary Syndrome, a condition that affects between 5 and 10% of women of reproductive age. This syndrome can cause increased body hair and acne, irregular menstrual periods, and fertility problems.

PCOS is the most common endocrine disorder in women of reproductive age, but, at the same time, it is one of the most unknown pathologies among the general population. It can also lead to the development of other diseases such as type 2 diabetes, cancer before menopause and anxiety or depression, which has an impact on the quality of life of these women.

At ASPHALION, we are proud regulatory partners of this EU-funded HORIZON project. We are committed to improving women’s health!

The clinical trial is aimed for the first time at treating the cause of the condition, rather than simply alleviating its symptoms, as is currently the case. Women diagnosed with Polycystic Ovary Syndrome between 12 and 24 years old can participate in this clinical trial if they have irregular menstruation, excess hair growth and/or persistent and severe acne. The recruitment period spans until April 2024.

People interested in taking part in the clinical trial can contact the research staff via the website: https://spiomet4health.eu/the-clinical-trial/#en or by sending an e-mail to: info@spiomet4health.eu.

For further information, you can contact us at: horizon@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

NABIHEAL project | Progress meeting

ASPHALION is proud member of the NABIHEAL EU-funded project consortium, ensuring the compliance with regulatory standards during the pre-clinical development of the innovative NABIHEAL product development to facilitate future fast translation to clinical setting

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting